Genetics Generation Advancement Corp.(TW:4160)
NT$35.55-0.15 (-0.42%)
TW:4160
Genetics Generation Advancement Corp. financials statements
NT$35.55
At close:-0.15 (-0.42%)
Genetics Generation Advancement Corp. (4160) Ratios
Genetics Generation Advancement Corp. Ratios
TW:4160's free cash flow for Q2 2026 was NT$-13.99M. For the 2026 fiscal year, TW:4160's free cash flow was decreased by NT$-5.67M and operating cash flow was NT$-8.32M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.10 | 3.32 | 2.95 | 3.76 | 3.45 |
| Quick Ratio | 2.74 | 3.12 | 2.73 | 3.47 | 2.88 |
| Cash Ratio | 0.33 | 0.77 | 0.83 | 0.54 | 0.82 |
| Solvency Ratio | 0.23 | 0.43 | 0.27 | 0.34 | 0.17 |
| Operating Cash Flow Ratio | -0.09 | 0.48 | 0.43 | 0.49 | 0.07 |
| Short-Term Operating Cash Flow Coverage | -0.26 | 2.65 | 2.17 | 61.60 | 149.47 |
| Net Current Asset Value | NT$ 413.90M | NT$ 388.98M | NT$ 291.67M | NT$ 291.14M | NT$ 253.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.06 | 0.08 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.13 | 0.07 | 0.11 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.12 | 0.07 | 0.10 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.34 | 1.31 | 1.38 | 1.31 | 1.33 |
| Debt Service Coverage Ratio | 0.44 | 2.34 | 1.43 | 38.82 | 207.84 |
| Interest Coverage Ratio | 18.50 | 94.89 | 44.44 | 320.87 | 263.05 |
| Debt to Market Cap | 0.06 | 0.02 | 0.03 | 0.00 | 0.00 |
| Interest Debt Per Share | 3.01 | 1.56 | 1.86 | 0.14 | 0.10 |
| Net Debt to EBITDA | 0.39 | -1.02 | -1.56 | -1.23 | -4.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.52% | 42.31% | 39.97% | 41.33% | 37.63% |
| EBIT Margin | 1.96% | 10.26% | 5.93% | 6.08% | 1.97% |
| EBITDA Margin | 6.17% | 12.99% | 8.54% | 8.03% | 3.94% |
| Operating Profit Margin | 1.96% | 7.48% | 3.14% | 6.21% | 1.97% |
| Pretax Profit Margin | 4.55% | 10.18% | 5.86% | 6.06% | 1.96% |
| Net Profit Margin | 3.56% | 8.26% | 4.82% | 4.70% | 1.51% |
| Continuous Operations Profit Margin | 3.56% | 8.29% | 4.86% | 4.74% | 1.54% |
| Net Income Per EBT | 78.26% | 81.17% | 82.22% | 77.52% | 76.88% |
| EBT Per EBIT | 231.92% | 136.04% | 187.03% | 97.59% | 99.40% |
| Return on Assets (ROA) | 2.66% | 7.55% | 4.80% | 5.65% | 1.85% |
| Return on Equity (ROE) | 3.57% | 9.89% | 6.64% | 7.41% | 2.46% |
| Return on Capital Employed (ROCE) | 1.95% | 8.91% | 4.22% | 9.73% | 3.20% |
| Return on Invested Capital (ROIC) | 1.36% | 6.78% | 3.21% | 7.57% | 2.51% |
| Return on Tangible Assets | 2.74% | 7.76% | 4.98% | 5.96% | 1.97% |
| Earnings Yield | 1.69% | 3.14% | 3.03% | 4.27% | 1.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.78 | 6.46 | 5.86 | 5.46 | 6.21 |
| Payables Turnover | 6.54 | 8.91 | 8.26 | 7.90 | 8.35 |
| Inventory Turnover | 4.95 | 10.92 | 10.22 | 10.27 | 5.43 |
| Fixed Asset Turnover | 9.80 | 13.58 | 15.82 | 23.04 | 22.76 |
| Asset Turnover | 0.75 | 0.91 | 1.00 | 1.20 | 1.22 |
| Working Capital Turnover Ratio | 1.49 | 1.91 | 1.99 | 2.00 | 2.06 |
| Cash Conversion Cycle | 94.33 | 48.97 | 53.77 | 56.18 | 82.35 |
| Days of Sales Outstanding | 76.39 | 56.48 | 62.27 | 66.84 | 58.82 |
| Days of Inventory Outstanding | 73.73 | 33.44 | 35.71 | 35.54 | 67.26 |
| Days of Payables Outstanding | 55.79 | 40.95 | 44.21 | 46.20 | 43.72 |
| Operating Cycle | 150.12 | 89.92 | 97.98 | 102.38 | 126.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.68 | 3.06 | 2.50 | 2.04 | 0.29 |
| Free Cash Flow Per Share | -1.85 | 2.08 | 2.31 | 1.72 | -0.12 |
| Dividend Paid and CapEx Coverage Ratio | -0.23 | 2.10 | 4.00 | 3.41 | 0.70 |
| Capital Expenditure Coverage Ratio | -0.59 | 3.14 | 13.07 | 6.36 | 0.70 |
| Operating Cash Flow Coverage Ratio | -0.23 | 1.98 | 1.36 | 15.55 | 3.03 |
| Operating Cash Flow to Sales Ratio | -0.03 | 0.12 | 0.11 | 0.09 | 0.01 |
| Free Cash Flow Yield | -3.90% | 3.19% | 6.56% | 7.25% | -0.57% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 59.31 | 31.88 | 32.97 | 23.49 | 69.26 |
| Price-to-Sales (P/S) Ratio | 2.11 | 2.64 | 1.59 | 1.10 | 1.05 |
| Price-to-Book (P/B) Ratio | 2.12 | 3.15 | 2.19 | 1.73 | 1.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -25.64 | 31.37 | 15.25 | 13.80 | -175.61 |
| Price-to-Operating Cash Flow Ratio | -69.42 | 21.37 | 14.09 | 11.63 | 74.47 |
| Price-to-Earnings Growth (PEG) Ratio | -0.97 | 0.35 | 5.55 | 0.10 | -0.46 |
| Enterprise Value Multiple | 34.58 | 19.28 | 17.05 | 12.46 | 22.59 |
| Enterprise Value | 1.29B | 1.66B | 862.66M | 548.49M | 462.58M |
| EV to EBITDA | 34.58 | 19.28 | 17.05 | 12.46 | 22.59 |
| EV to Sales | 2.13 | 2.50 | 1.46 | 1.00 | 0.89 |
| EV to Free Cash Flow | -25.93 | 29.79 | 13.97 | 12.56 | -148.93 |
| EV to Operating Cash Flow | -70.21 | 20.30 | 12.90 | 10.59 | 63.16 |
| Tangible Book Value Per Share | 21.55 | 20.00 | 15.29 | 12.74 | 11.50 |
| Shareholders’ Equity Per Share | 22.43 | 20.72 | 16.10 | 13.68 | 12.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.19 | 0.17 | 0.22 | 0.21 |
| Revenue Per Share | 22.49 | 24.80 | 22.19 | 21.56 | 20.45 |
| Net Income Per Share | 0.80 | 2.05 | 1.07 | 1.01 | 0.31 |
| Tax Burden | 0.78 | 0.81 | 0.82 | 0.78 | 0.77 |
| Interest Burden | 2.32 | 0.99 | 0.99 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.10 | 0.10 | 0.09 | 0.10 | 0.10 |
| SG&A to Revenue | 0.29 | 0.25 | 0.28 | 0.28 | 0.29 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.67 | 1.21 | 1.92 | 1.56 | 0.72 |
Currency in TWD
